120 related articles for article (PubMed ID: 12725416)
1. Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology.
Conner P; Söderqvist G; Skoog L; Gräser T; Walter F; Tani E; Carlström K; von Schoultz B
Breast Cancer Res Treat; 2003 Mar; 78(2):159-65. PubMed ID: 12725416
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolon and continuous combined estrogen-progestogen treatment.
Conner P; Christow A; Kersemaekers W; Söderqvist G; Skoog L; Carlström K; Tani E; Mol-Arts M; von Schoultz B
Climacteric; 2004 Mar; 7(1):50-8. PubMed ID: 15259283
[TBL] [Abstract][Full Text] [Related]
3. Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.
Georgiev DB; Manassiev NA
Medscape Womens Health; 2002; 7(4):1. PubMed ID: 12466733
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment.
von Schoultz B
Climacteric; 2003 Aug; 6 Suppl 2():24-32. PubMed ID: 14669841
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women.
Gräser T; Koytchev R; Müller A; Oettel M
Climacteric; 2000 Jun; 3(2):109-18. PubMed ID: 11910651
[TBL] [Abstract][Full Text] [Related]
6. Breast epithelial proliferation in postmenopausal women evaluated through fine-needle-aspiration cytology.
Conner P; Skoog L; Söderqvist G
Climacteric; 2001 Mar; 4(1):7-12. PubMed ID: 11379380
[TBL] [Abstract][Full Text] [Related]
7. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
Kimmerle R; Heinemann L; Heise T; Bender R; Weyer C; Hirschberger S; Berger M
Menopause; 1999; 6(1):36-42. PubMed ID: 10100178
[TBL] [Abstract][Full Text] [Related]
8. Estrone - a partial estradiol antagonist in the normal breast.
Lundström E; Conner P; Naessén S; Löfgren L; Carlström K; Söderqvist G
Gynecol Endocrinol; 2015; 31(9):747-9. PubMed ID: 26190536
[TBL] [Abstract][Full Text] [Related]
9. Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy.
Conner P; Svane G; Azavedo E; Söderqvist G; Carlström K; Gräser T; Walter F; von Schoultz B
Fertil Steril; 2004 Jun; 81(6):1617-23. PubMed ID: 15193485
[TBL] [Abstract][Full Text] [Related]
10. A one-year randomized double-blind, multicentre study to evaluate the effects of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal women.
Endrikat J; Lange E; Kunz M; Schmidt W; Graeser T
Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):229-39. PubMed ID: 17763261
[TBL] [Abstract][Full Text] [Related]
11. Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest.
Saletu B
Climacteric; 2003 Aug; 6 Suppl 2():37-45. PubMed ID: 14669843
[TBL] [Abstract][Full Text] [Related]
12. Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density.
Lundström E; Bygdeson M; Svane G; Azavedo E; von Schoultz B
Climacteric; 2007 Jun; 10(3):249-56. PubMed ID: 17487652
[TBL] [Abstract][Full Text] [Related]
13. Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women.
Hofling M; Hirschberg AL; Skoog L; Tani E; Hägerström T; von Schoultz B
Menopause; 2007; 14(2):183-90. PubMed ID: 17108847
[TBL] [Abstract][Full Text] [Related]
14. The effects of postmenopausal hormone replacement therapy and oral contraceptives on the endogenous estradiol metabolism.
Mueck AO; Seeger H; Gräser T; Oettel M; Lippert TH
Horm Metab Res; 2001 Dec; 33(12):744-7. PubMed ID: 11753761
[TBL] [Abstract][Full Text] [Related]
15. Effects of short-term estradiol and norethindrone acetate treatment on the breasts of normal postmenopausal women.
Cheng G; Butler R; Warner M; Gustafsson JÅ; Wilczek B; Landgren BM
Menopause; 2013 May; 20(5):496-503. PubMed ID: 23615640
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy dependent changes in breast cancer-related gene expression in breast tissue of healthy postmenopausal women.
Sieuwerts AM; De Napoli G; van Galen A; Kloosterboer HJ; de Weerd V; Zhang H; Martens JW; Foekens JA; De Geyter C
Mol Oncol; 2011 Dec; 5(6):504-16. PubMed ID: 21956102
[TBL] [Abstract][Full Text] [Related]
17. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density.
Lundström E; Christow A; Kersemaekers W; Svane G; Azavedo E; Söderqvist G; Mol-Arts M; Barkfeldt J; von Schoultz B
Am J Obstet Gynecol; 2002 Apr; 186(4):717-22. PubMed ID: 11967497
[TBL] [Abstract][Full Text] [Related]
18. The role of antiandrogens in hormone replacement therapy.
Schneider HP
Climacteric; 2000 Dec; 3 Suppl 2():21-7. PubMed ID: 11379383
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
[TBL] [Abstract][Full Text] [Related]
20. Effects of postmenopausal hormone replacement therapy on body fat composition.
Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
